Evaluation of antitumor effects of aspirin and LGK974 drugs on cellular signaling pathways, cell cycle and apoptosis in colorectal cancer cell lines compared to oxaliplatin drug
- PMID: 31233627
- DOI: 10.1111/fcp.12492
Evaluation of antitumor effects of aspirin and LGK974 drugs on cellular signaling pathways, cell cycle and apoptosis in colorectal cancer cell lines compared to oxaliplatin drug
Abstract
Colorectal cancer (CRC) is one of the most common gastrointestinal malignancies. Despite recent advances in the treatment for CRC, resistance to chemotherapy drugs and recurrence of the tumor are among the main problems for treatment in this cancer. The MTT assay was performed to assess the cytotoxic effects of drugs on CRC cell lines (SW742 and SW480) and normal colon cells. Three-dimensional culture (spheroid) was also used to evaluate the effect of drugs on tumor cell masses. The rate of expression of genes was also evaluated using Real-Time PCR. The analysis of the results demonstrated that aspirin and LGK974 have cytotoxic effects on CRC cell lines, and in the IC50 dose, they disintegrate the cancerous cell masses. These drugs reduce the invasion and increase apoptosis in SW742 and SW480 cell lines. A decrease in the expression of WNT, AXIN, TCF and APC genes and an increase in the expression of β-catenin gene in the WNT signaling pathway were revealed. The genes involved in the MAPK signaling pathway such as ERK, JNK, KRAS and MEK showed a decrease in expression and a increase in expression of RAF gene. In the apoptotic pathway, increased expression of BAX and decreased expression of BCL-2 were reported. Also, decreased expression of P53, cyclin D1 and COX-2 was observed. This study demonstrates that aspirin and LGK974 could be effective in inhibiting the signaling pathways of WNT and MAPK, arresting cell cycle and inducing apoptosis in CRC cell lines.
Keywords: LGK974; aspirin; colorectal cancer.
© 2019 Société Française de Pharmacologie et de Thérapeutique.
Similar articles
-
Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.Biomed Res Int. 2020 Feb 13;2020:2527643. doi: 10.1155/2020/2527643. eCollection 2020. Biomed Res Int. 2020. PMID: 32104684 Free PMC article.
-
Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.Life Sci. 2018 Aug 15;207:532-549. doi: 10.1016/j.lfs.2018.06.035. Epub 2018 Jul 1. Life Sci. 2018. PMID: 29972765
-
Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.J Cell Biochem. 2019 Sep;120(9):14585-14593. doi: 10.1002/jcb.28720. Epub 2019 Apr 18. J Cell Biochem. 2019. PMID: 30998268
-
Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.Pharmacol Res. 2021 May;167:105532. doi: 10.1016/j.phrs.2021.105532. Epub 2021 Mar 4. Pharmacol Res. 2021. PMID: 33677106 Review.
-
Therapeutic Potential of Polyphenols and their Nanoformulations in the Treatment of Colorectal Cancer.Anticancer Agents Med Chem. 2021 Oct 28;21(16):2117-2129. doi: 10.2174/1871520621666201231144007. Anticancer Agents Med Chem. 2021. PMID: 33390126 Review.
Cited by
-
Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer.Infect Agent Cancer. 2023 Aug 29;18(1):48. doi: 10.1186/s13027-023-00523-w. Infect Agent Cancer. 2023. PMID: 37644520 Free PMC article.
-
An integrative review of nonobvious puzzles of cellular and molecular cardiooncology.Cell Mol Biol Lett. 2023 May 23;28(1):44. doi: 10.1186/s11658-023-00451-y. Cell Mol Biol Lett. 2023. PMID: 37221467 Free PMC article. Review.
-
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.Oncologist. 2023 Mar 17;28(3):230-238. doi: 10.1093/oncolo/oyad007. Oncologist. 2023. PMID: 36811382 Free PMC article. Clinical Trial.
-
Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review).Int J Oncol. 2023 Feb;62(2):24. doi: 10.3892/ijo.2022.5472. Epub 2022 Dec 29. Int J Oncol. 2023. PMID: 36579676 Free PMC article. Review.
-
Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal cancers through porcupine inhibition.Pharmacol Ther. 2022 Oct;238:108179. doi: 10.1016/j.pharmthera.2022.108179. Epub 2022 Mar 28. Pharmacol Ther. 2022. PMID: 35358569 Free PMC article. Review.
References
-
- Mármol I., Sánchez-de-Diego C., Pradilla Dieste A., Cerrada E., Rodriguez Yoldi M.J. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int. J. Mol. Sci. (2017) 18 pii: E197.
-
- Gharagozloo M., Mirzaei H.R., Bagherpour B. et al. Cell cycle analysis of the CD133(+) and CD133(-) cells isolated from human colorectal cancer. J. Cancer Res. Ther. (2012) 8 399-403.
-
- Johnson C.M., Wei C., Ensor J.E. et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control (2013) 24 1207-1222.
-
- Mirzaei H., Salehi H., Sahebkar A. et al. Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity. J. Res. Med. Sci. (2016) 21 64.
-
- Cartwright T.H. Treatment decisions after diagnosis of metastatic colorectal cancer. Clin. Colorectal Cancer (2012) 11 155-166.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
